Q4 2016 Holdings
Filed 2017-02-14 | 77 holdings | $88.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $29.4M | 2,071,964 | 33.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $26.5M | 976,286 | 29.9% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $14.6M | 519,090 | 16.5% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $7.1M | 455,515 | 8.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.1M | 371,636 | 4.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.3M | 162,254 | 3.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.8M | 198,526 | 3.2% |
| Proteostasis Therapeutics in | COM | 74373B109 | $46.6K | 3,804,027 | 0.1% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $45.4K | 1,425,000 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $43.7K | 601,044 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $32.9K | 1,581,604 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $32.5K | 410,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $31.2K | 2,652,436 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $25.6K | 1,951,263 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.6K | 841,752 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $21.4K | 334,044 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $21.1K | 2,500,000 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $20.9K | 2,333,333 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $18.7K | 1,445,090 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $15.8K | 720,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $14.2K | 2,940,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.9K | 359,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $13.3K | 507,907 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $12.1K | 112,867 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $12.1K | 537,000 | 0.0% |
| Inc Resh Hldgs Inc | CL A | 45329R109 | $10.5K | 200,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $10.1K | 1,150,000 | 0.0% |
| Fulgent Genetics Inc(FLGT) | COM | 359664109 | $9.9K | 857,663 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $9.7K | 975,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $9.4K | 1,909,000 | 0.0% |
| Synergy Pharmaceuticals del | COM NEW | 871639308 | $9.1K | 1,500,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $8.2K | 449,660 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.8K | 110,842 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $7.5K | 480,501 | 0.0% |
| Curis Inc | COM | 231269101 | $7.4K | 2,410,900 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $7.1K | 900,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $6.8K | 2,868,700 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $6.7K | 3,842,966 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $5.9K | 1,421,000 | 0.0% |
| Pfenex Inc | COM | 717071104 | $5.7K | 632,559 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $5.5K | 538,422 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.4K | 90,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $5.2K | 172,083 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $5.1K | 339,175 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $4.9K | 603,000 | 0.0% |
| Intec Pharma LTD Jerusalem | SHS | M53644106 | $4.6K | 809,804 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $4.4K | 767,466 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $3.6K | 1,000,000 | 0.0% |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | $3.3K | 124,220 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $3.3K | 127,451 | 0.0% |